title: What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?
authors.affiliation: Colorado Center for Bone Research, 3190 South Wadsworth Blvd, Lakewood, CO 80227, USA. MillerCCBR@aol.com
authors.forename: P D
authors.initials: PD
authors.lastname: Miller
authors.forename: R J
authors.initials: RJ
authors.lastname: Derman
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000503:physiopathology; D058866:Osteoporotic Fractures / Q000503:physiopathology / Q000517:prevention & control; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D050071:Bone Density Conservation Agents